Canada's Farm Show reports millions of dollars in sales

Jun 29, 2022

Organizers are extremely pleased with the results for Canada's Farm Show which brought producers and exhibitors from across Alberta, Saskatchewan, Manitoba and the world to the event.

Kirk Westgard, Vice President of Regina Exhibition Association says during the three day show $76 million in international sales were reported, as well as a $100 million investment in the agri-value chain.

He notes people were happy to be back face-to-face doing business with attendance for the show on par with 2019 levels.

"Doing the comparison I know we're about 93% of what we were so it was looking good. We're on target for a show that changed how we operate and went all indoors. Coming off of COVID and what's going on around the globe we're very happy with where the attendance is at."

Westgard says exhibitors and visitors to the show were pleased with the new Tuesday to Thursday show dates, and indoor format which meant they didn’t have to fight the wind, rain, and heat.

This year also marked the final event for Show Manager Shirley Janezcko who is officially retiring.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.